Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals Inc (VRCA)
0.4405 x 5 0.4996 x 2
Post-market by (Cboe BZX)
0.4680 +0.0026 (+0.56%) 04/22/25 [NASDAQ]
0.4405 x 5 0.4996 x 2
Post-market 0.4914 +0.0234 (+5.00%) 18:38 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.4461
Day High
0.4996
Open 0.4730
Previous Close 0.4654 0.4654
Volume 259,000 259,000
Avg Vol 476,620 476,620
Stochastic %K 34.52% 34.52%
Weighted Alpha -85.25 -85.25
5-Day Change -0.0849 (-15.36%) -0.0849 (-15.36%)
52-Week Range 0.3816 - 11.4100 0.3816 - 11.4100
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,714
  • Shares Outstanding, K 91,780
  • Annual Sales, $ 7,570 K
  • Annual Income, $ -76,580 K
  • EBIT $ -66 M
  • EBITDA $ -65 M
  • 60-Month Beta 1.68
  • Price/Sales 5.95
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.54
  • Most Recent Earnings $-0.24 on 03/11/25
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Options Overview Details

View History
  • Implied Volatility 454.88% ( -71.50%)
  • Historical Volatility 154.79%
  • IV Percentile 65%
  • IV Rank 41.32%
  • IV High 1,062.55% on 02/21/25
  • IV Low 27.00% on 09/19/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 412
  • Open Int (30-Day) 641

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +77.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3816 +22.64%
on 04/03/25
Period Open: 0.5580
0.6511 -28.12%
on 04/08/25
-0.0900 (-16.13%)
since 03/21/25
3-Month
0.3816 +22.64%
on 04/03/25
Period Open: 0.7163
0.7799 -39.99%
on 02/18/25
-0.2483 (-34.66%)
since 01/22/25
52-Week
0.3816 +22.64%
on 04/03/25
Period Open: 6.7900
11.4100 -95.90%
on 05/14/24
-6.3220 (-93.11%)
since 04/22/24

Most Recent Stories

More News
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025

VRCA : 0.4680 (+0.56%)
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

VRCA : 0.4680 (+0.56%)
Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

VRCA : 0.4680 (+0.56%)
Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer

VRCA : 0.4680 (+0.56%)
Verrica Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

VRCA : 0.4680 (+0.56%)
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025

VRCA : 0.4680 (+0.56%)
Verrica Pharmaceuticals to Participate in the TD Cowen 45th Annual Health Care Conference in Boston

VRCA : 0.4680 (+0.56%)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins

Vancouver, BC – February 18, 2025 – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers), there is still cause...

ONCY : 0.6000 (+4.35%)
ALLO : 1.5900 (+11.97%)
VRCA : 0.4680 (+0.56%)
ONC.TO : 0.84 (+6.33%)
OSTX : 1.5200 (+2.01%)
IBRX : 2.69 (+7.17%)
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – Despite optimism coming from the launch of Project Stargate (a $500 billion investment in AI data centers),...

ALLO : 1.5900 (+11.97%)
ONCY : 0.6000 (+4.35%)
VRCA : 0.4680 (+0.56%)
ONC.TO : 0.84 (+6.33%)
IBRX : 2.69 (+7.17%)
OSTX : 1.5200 (+2.01%)
Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference

VRCA : 0.4680 (+0.56%)

Business Summary

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.

See More

Key Turning Points

3rd Resistance Point 0.5499
2nd Resistance Point 0.5247
1st Resistance Point 0.4964
Last Price 0.4680
1st Support Level 0.4429
2nd Support Level 0.4177
3rd Support Level 0.3894

See More

52-Week High 11.4100
Fibonacci 61.8% 7.1972
Fibonacci 50% 5.8958
Fibonacci 38.2% 4.5944
Last Price 0.4680
52-Week Low 0.3816

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro